Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Glycine antagonist (GV150526) in acute stroke: a multicentre, double-blind placebo-controlled phase II trial.

Lees KR, Lavelle JF, Cunha L, Diener HC, Sanders EA, Tack P, Wester P; GAIN Phase II European Study Group..

Cerebrovasc Dis. 2001;11(1):20-9.

PMID:
11173790
4.

Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial.

Sacco RL, DeRosa JT, Haley EC Jr, Levin B, Ordronneau P, Phillips SJ, Rundek T, Snipes RG, Thompson JL; Glycine Antagonist in Neuroprotection Americas Investigators..

JAMA. 2001 Apr 4;285(13):1719-28.

PMID:
11277826
5.

Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.

Diener HC, AlKhedr A, Busse O, Hacke W, Zingmark PH, Jonsson N, Basun H; Study group..

J Neurol. 2002 May;249(5):561-8.

PMID:
12021946
6.

Neuroprotective effects of glycine for therapy of acute ischaemic stroke.

Gusev EI, Skvortsova VI, Dambinova SA, Raevskiy KS, Alekseev AA, Bashkatova VG, Kovalenko AV, Kudrin VS, Yakovleva EV.

Cerebrovasc Dis. 2000 Jan-Feb;10(1):49-60.

PMID:
10629347
7.

Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators.

Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, Orgogozo JM, Whitehead J.

Lancet. 2000 Jun 3;355(9219):1949-54.

PMID:
10859040
8.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
9.

A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain.

Wallace MS, Rowbotham MC, Katz NP, Dworkin RH, Dotson RM, Galer BS, Rauck RL, Backonja MM, Quessy SN, Meisner PD.

Neurology. 2002 Dec 10;59(11):1694-700.

PMID:
12473754
10.

Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy.

Warach S, Kaufman D, Chiu D, Devlin T, Luby M, Rashid A, Clayton L, Kaste M, Lees KR, Sacco R, Fisher M; GAIN MRI Substudy..

Cerebrovasc Dis. 2006;21(1-2):106-11. Epub 2005 Dec 9.

12.

Fiblast (trafermin) in acute stroke: results of the European-Australian phase II/III safety and efficacy trial.

Bogousslavsky J, Victor SJ, Salinas EO, Pallay A, Donnan GA, Fieschi C, Kaste M, Orgogozo JM, Chamorro A, Desmet A; European-Australian Fiblast (Trafermin) in Acute Stroke Group..

Cerebrovasc Dis. 2002;14(3-4):239-51.

PMID:
12403958
13.

Reassessment of defibrase in treatment of acute cerebral infarction: a multicenter, randomized, double-blind, placebo-controlled trial.

Cooperative Group for Reassessment of Defibrase..

Chin Med Sci J. 2005 Sep;20(3):151-8.

PMID:
16261883
14.

The neuroprotective activity of the glycine receptor antagonist GV150526: an in vivo study by magnetic resonance imaging.

Reggiani A, Pietra C, Arban R, Marzola P, Guerrini U, Ziviani L, Boicelli A, Sbarbati A, Osculati F.

Eur J Pharmacol. 2001 May 11;419(2-3):147-53.

PMID:
11426836
15.

The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke: a double-blind, multicentre, placebo-controlled safety and tolerability study.

Walters MR, Kaste M, Lees KR, Diener HC, Hommel M, De Keyser J, Steiner H, Versavel M.

Cerebrovasc Dis. 2005;20(5):304-9. Epub 2005 Aug 30.

PMID:
16131799
16.

Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo.

Diener HC, Cortens M, Ford G, Grotta J, Hacke W, Kaste M, Koudstaal PJ, Wessel T.

Stroke. 2000 Nov;31(11):2543-51.

17.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
18.

The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator-treated stroke (CLASS-T): final results.

Lyden P, Jacoby M, Schim J, Albers G, Mazzeo P, Ashwood T, Nordlund A, Odergren T.

Neurology. 2001 Oct 9;57(7):1199-205.

PMID:
11591835
19.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
20.

Effectiveness of high dose dexamethasone in the treatment of acute stroke.

Ogun SA, Odusote KA.

West Afr J Med. 2001 Jan-Mar;20(1):1-6.

PMID:
11505880

Supplemental Content

Support Center